Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2012

View Archived Issues

RP-7047 evaluated for the treatment of acute lymphoblastic lymphoma

New protein kinase inhibitors disclosed by China State Institute of Pharmaceutical Industry

Gynecologic Oncology Group begins phase II trial of dalantercept

FDA committee recommends approval of GSK's H5N1 influenza vaccine candidate

Incyte earns milestone payment from Lilly

Novel procognitive drug developed for the treatment of dementia-like diseases

TAS-117 demonstrates potent antitumor activity alone and in combination

Second-generation Japanese encephalitis vaccine proves effective in healthy children

Results from first-in-human trial of Na-GST-1 hookworm vaccine presented

Scientists at Origenis design novel protein kinase inhibitors

Brazilian researchers disclose new radioactive iodine compounds

Novel JAK3 inhibitors presented by Cellzome (GlaxoSmithKline)

Biota Scientific Management divulges new antibacterial agents

Bristol-Myers Squibb gains option rights for Biocon drug

Novel synaptic vesicle glycoprotein ligands synthesized by UCB

Zaltrap receives positive CHMP opinion for metastatic colorectal cancer

Nerviano Medical Sciences presents new JAK2 inhibitors

Integral Molecular and Crystal Bioscience enter research collaboration

POZEN plans NDA for integrated aspirin therapy following completion of bioavailability study

Dynavax reports findings from FDA advisory committee meeting for Heplisav BLA

Anti-NOD27 antibodies may possibly provide a novel biomarker in SLE

CHMP recommends approval of Novartis's meningococcal group B vaccine

Palobiofarma's PBF-509 to enter first-in-human phase I trial

FDA assigns action date for Orexo's Zubsolv NDA

EMA committee recommends approval of lixisenatide

Janssen Research & Development establishes global trial investigator databank

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...